SMARCB1 and neoplasm: In contrast, one patient died 11 months after initial resection with multifocal intracranial disease; however, this tumor additionally harbored a subclonal SMARCB1 mutation and clusters of embryonal cells making it histologically and molecularly distinctive from the other cases.